International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety

Alexandra L. Quittner, Janice Abbott, Anna M. Georgiopoulos, Lutz Goldbeck, Beth Smith, Sarah E. Hempstead, Bruce Marshall, Kathryn A. Sabadosa, Stuart Elborn, Michael Boyle, Amanda Crossan, Silvia Gartner, Manfred Gerlach, Jennifer Rounds, Martin Hug, Christopher Kvam, Michelle Macias, Amy Mueller, Jacquelien Noordhoek, Paul RamchandiKim Reno, Kristin Riekert, Ahmet Uluer, Jacquelyn Zirbes

Research output: Contribution to journalArticle

Abstract

Studies measuring psychological distress in individuals with cystic fibrosis (CF) have found high rates of both depression and anxiety. Psychological symptoms in both individuals with CF and parent caregivers have been associated with decreased lung function, lower body mass index, worse adherence, worse health-related quality of life, more frequent hospitalisations and increased healthcare costs. To identify and treat depression and anxiety in CF, the CF Foundation and the European CF Society invited a panel of experts, including physicians, psychologists, psychiatrists, nurses, social workers, a pharmacist, parents and an individual with CF, to develop consensus recommendations for clinical care. Over 18 months, this 22-member committee was divided into four workgroups: Screening; Psychological Interventions; Pharmacological Treatments and Implementation and Future Research, and used the Population, Intervention, Comparison, Outcome methodology to develop questions for literature search and review. Searches were conducted in PubMed, PsychINFO, ScienceDirect, Google Scholar, Psychiatry online and ABDATA by a methodologist at Dartmouth. The committee reviewed 344 articles, drafted statements and set an 80% acceptance for each recommendation statement as a consensus threshold prior to an anonymous voting process. Fifteen guideline recommendation statements for screening and treatment of depression and anxiety in individuals with CF and parent caregivers were finalised by vote. As these recommendations are implemented in CF centres internationally, the process of dissemination, implementation and resource provision should be closely monitored to assess barriers and concerns, validity and use.

Original languageEnglish (US)
Pages (from-to)26-34
Number of pages9
JournalThorax
Volume71
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Cystic Fibrosis
Consensus
Mental Health
Anxiety
Depression
Psychology
Caregivers
Psychiatry
Committee Membership
Politics
Pharmacists
PubMed
Health Care Costs
Hospitalization
Body Mass Index
Parents
Nurses
Quality of Life
Pharmacology
Guidelines

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

International Committee on Mental Health in Cystic Fibrosis : Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety. / Quittner, Alexandra L.; Abbott, Janice; Georgiopoulos, Anna M.; Goldbeck, Lutz; Smith, Beth; Hempstead, Sarah E.; Marshall, Bruce; Sabadosa, Kathryn A.; Elborn, Stuart; Boyle, Michael; Crossan, Amanda; Gartner, Silvia; Gerlach, Manfred; Rounds, Jennifer; Hug, Martin; Kvam, Christopher; Macias, Michelle; Mueller, Amy; Noordhoek, Jacquelien; Ramchandi, Paul; Reno, Kim; Riekert, Kristin; Uluer, Ahmet; Zirbes, Jacquelyn.

In: Thorax, Vol. 71, No. 1, 01.01.2016, p. 26-34.

Research output: Contribution to journalArticle

Quittner, AL, Abbott, J, Georgiopoulos, AM, Goldbeck, L, Smith, B, Hempstead, SE, Marshall, B, Sabadosa, KA, Elborn, S, Boyle, M, Crossan, A, Gartner, S, Gerlach, M, Rounds, J, Hug, M, Kvam, C, Macias, M, Mueller, A, Noordhoek, J, Ramchandi, P, Reno, K, Riekert, K, Uluer, A & Zirbes, J 2016, 'International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety', Thorax, vol. 71, no. 1, pp. 26-34. https://doi.org/10.1136/thoraxjnl-2015-207488
Quittner, Alexandra L. ; Abbott, Janice ; Georgiopoulos, Anna M. ; Goldbeck, Lutz ; Smith, Beth ; Hempstead, Sarah E. ; Marshall, Bruce ; Sabadosa, Kathryn A. ; Elborn, Stuart ; Boyle, Michael ; Crossan, Amanda ; Gartner, Silvia ; Gerlach, Manfred ; Rounds, Jennifer ; Hug, Martin ; Kvam, Christopher ; Macias, Michelle ; Mueller, Amy ; Noordhoek, Jacquelien ; Ramchandi, Paul ; Reno, Kim ; Riekert, Kristin ; Uluer, Ahmet ; Zirbes, Jacquelyn. / International Committee on Mental Health in Cystic Fibrosis : Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety. In: Thorax. 2016 ; Vol. 71, No. 1. pp. 26-34.
@article{7cf07808392d43f5b908fe4a807c62c4,
title = "International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety",
abstract = "Studies measuring psychological distress in individuals with cystic fibrosis (CF) have found high rates of both depression and anxiety. Psychological symptoms in both individuals with CF and parent caregivers have been associated with decreased lung function, lower body mass index, worse adherence, worse health-related quality of life, more frequent hospitalisations and increased healthcare costs. To identify and treat depression and anxiety in CF, the CF Foundation and the European CF Society invited a panel of experts, including physicians, psychologists, psychiatrists, nurses, social workers, a pharmacist, parents and an individual with CF, to develop consensus recommendations for clinical care. Over 18 months, this 22-member committee was divided into four workgroups: Screening; Psychological Interventions; Pharmacological Treatments and Implementation and Future Research, and used the Population, Intervention, Comparison, Outcome methodology to develop questions for literature search and review. Searches were conducted in PubMed, PsychINFO, ScienceDirect, Google Scholar, Psychiatry online and ABDATA by a methodologist at Dartmouth. The committee reviewed 344 articles, drafted statements and set an 80{\%} acceptance for each recommendation statement as a consensus threshold prior to an anonymous voting process. Fifteen guideline recommendation statements for screening and treatment of depression and anxiety in individuals with CF and parent caregivers were finalised by vote. As these recommendations are implemented in CF centres internationally, the process of dissemination, implementation and resource provision should be closely monitored to assess barriers and concerns, validity and use.",
author = "Quittner, {Alexandra L.} and Janice Abbott and Georgiopoulos, {Anna M.} and Lutz Goldbeck and Beth Smith and Hempstead, {Sarah E.} and Bruce Marshall and Sabadosa, {Kathryn A.} and Stuart Elborn and Michael Boyle and Amanda Crossan and Silvia Gartner and Manfred Gerlach and Jennifer Rounds and Martin Hug and Christopher Kvam and Michelle Macias and Amy Mueller and Jacquelien Noordhoek and Paul Ramchandi and Kim Reno and Kristin Riekert and Ahmet Uluer and Jacquelyn Zirbes",
year = "2016",
month = "1",
day = "1",
doi = "10.1136/thoraxjnl-2015-207488",
language = "English (US)",
volume = "71",
pages = "26--34",
journal = "Thorax",
issn = "0040-6376",
publisher = "BMJ Publishing Group",
number = "1",

}

TY - JOUR

T1 - International Committee on Mental Health in Cystic Fibrosis

T2 - Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety

AU - Quittner, Alexandra L.

AU - Abbott, Janice

AU - Georgiopoulos, Anna M.

AU - Goldbeck, Lutz

AU - Smith, Beth

AU - Hempstead, Sarah E.

AU - Marshall, Bruce

AU - Sabadosa, Kathryn A.

AU - Elborn, Stuart

AU - Boyle, Michael

AU - Crossan, Amanda

AU - Gartner, Silvia

AU - Gerlach, Manfred

AU - Rounds, Jennifer

AU - Hug, Martin

AU - Kvam, Christopher

AU - Macias, Michelle

AU - Mueller, Amy

AU - Noordhoek, Jacquelien

AU - Ramchandi, Paul

AU - Reno, Kim

AU - Riekert, Kristin

AU - Uluer, Ahmet

AU - Zirbes, Jacquelyn

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Studies measuring psychological distress in individuals with cystic fibrosis (CF) have found high rates of both depression and anxiety. Psychological symptoms in both individuals with CF and parent caregivers have been associated with decreased lung function, lower body mass index, worse adherence, worse health-related quality of life, more frequent hospitalisations and increased healthcare costs. To identify and treat depression and anxiety in CF, the CF Foundation and the European CF Society invited a panel of experts, including physicians, psychologists, psychiatrists, nurses, social workers, a pharmacist, parents and an individual with CF, to develop consensus recommendations for clinical care. Over 18 months, this 22-member committee was divided into four workgroups: Screening; Psychological Interventions; Pharmacological Treatments and Implementation and Future Research, and used the Population, Intervention, Comparison, Outcome methodology to develop questions for literature search and review. Searches were conducted in PubMed, PsychINFO, ScienceDirect, Google Scholar, Psychiatry online and ABDATA by a methodologist at Dartmouth. The committee reviewed 344 articles, drafted statements and set an 80% acceptance for each recommendation statement as a consensus threshold prior to an anonymous voting process. Fifteen guideline recommendation statements for screening and treatment of depression and anxiety in individuals with CF and parent caregivers were finalised by vote. As these recommendations are implemented in CF centres internationally, the process of dissemination, implementation and resource provision should be closely monitored to assess barriers and concerns, validity and use.

AB - Studies measuring psychological distress in individuals with cystic fibrosis (CF) have found high rates of both depression and anxiety. Psychological symptoms in both individuals with CF and parent caregivers have been associated with decreased lung function, lower body mass index, worse adherence, worse health-related quality of life, more frequent hospitalisations and increased healthcare costs. To identify and treat depression and anxiety in CF, the CF Foundation and the European CF Society invited a panel of experts, including physicians, psychologists, psychiatrists, nurses, social workers, a pharmacist, parents and an individual with CF, to develop consensus recommendations for clinical care. Over 18 months, this 22-member committee was divided into four workgroups: Screening; Psychological Interventions; Pharmacological Treatments and Implementation and Future Research, and used the Population, Intervention, Comparison, Outcome methodology to develop questions for literature search and review. Searches were conducted in PubMed, PsychINFO, ScienceDirect, Google Scholar, Psychiatry online and ABDATA by a methodologist at Dartmouth. The committee reviewed 344 articles, drafted statements and set an 80% acceptance for each recommendation statement as a consensus threshold prior to an anonymous voting process. Fifteen guideline recommendation statements for screening and treatment of depression and anxiety in individuals with CF and parent caregivers were finalised by vote. As these recommendations are implemented in CF centres internationally, the process of dissemination, implementation and resource provision should be closely monitored to assess barriers and concerns, validity and use.

UR - http://www.scopus.com/inward/record.url?scp=84958206254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958206254&partnerID=8YFLogxK

U2 - 10.1136/thoraxjnl-2015-207488

DO - 10.1136/thoraxjnl-2015-207488

M3 - Article

C2 - 26452630

AN - SCOPUS:84958206254

VL - 71

SP - 26

EP - 34

JO - Thorax

JF - Thorax

SN - 0040-6376

IS - 1

ER -